I

Immucell CorpICCC

ImmuCell Corporation (Nasdaq: ICCC) is an animal-health biologics company that operates in the fast-growing market for calf health solutions. It develops, manufactures and commercializes the First Defense® line of products that provides Immediate Immunity through colostrum-derived, orally delivered antibodies against the principal viral and bacterial causes of scours. Scours (neonatal calf diarrhea) is one of the most prevalent and deadly diseases in neonatal calves.

US StocksHealthcareSmall CapDefense & AerospaceGrowth Stocks

ICCC の価格トレンド

Immucell Corp · TradingView フルチャート

NASDAQ:ICCC

オンチェーンアクティビティ